Family movie night can be fraught in biotech households.

Earlier this month, John Crowley, CEO of Amicus Therapeutics, cued up “Rise of the Planet of the Apes” as a refresher before the debut of its blockbuster sequel. Soon his living room played host to a man with roughly his job, working at a firm not unlike his, but whose greed and moral depravity made him the movie’s villain.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • As a caregiver for a stage IV cancer pt., I see too much worry in the private biotech sector about stockholders /corporate issues in general . When a dying pt. can’t call a co. to ask about compassionate use but you can call an 800 investors phone line 24/7 – there’s a problem . When PHRMA lobbyists gut the Andrea Sloan Compassionate Use Reform Act there’s a problem . And so on … they make amazing drugs but give pathetically little pre – approval access to their drugs – even as they promote the drugs for accelerated approval . The ” small ” biotechs cry that they’re too small to give compassion, as they pay their CEOs tens of millions $$. They could save more lives , prolong more lives , expand science – just by spending a few more million $$ on compassion for the dying. It would also gain them great PR . A few bigger co.’s are getting it, most are not. We pt.’s want a lot more than a cheap thank you at the end of a commercial.

  • Great article and very needed.
    Always something the bothers me. I call it Science Horror myself and I do think that for people that never visits a lab or had talked to a real scientist. Movies and TV series are the only times they get any exposure to it. Hence is important to call out this trend that doesn’t even take in account ethics committees or how long it takes to go from theory to human trials.
    I do like that we had seen a couple of movies were scientists are the heroes like “Interstellar” so I suggest you to do a sequel of this with science saving the world so we can at least promote those too.

  • Nice piece. There is also an interesting uptick in television treatments of dystopias such as ‘The Handmaid’s Tale’ and ‘The Man in the High Castle’ which may be related.

  • Big Pharma makes an easy villain because it’s so close to the truth. These corporations, like cigarette companies, are out to make money and they only care about the bottom line. They are skewing research and they produce drugs that do more harm than good. Often the most beneficial research is coming from government grant funded programs not from Big Pharma – they just take the results and try to profit off them. I do not deny that many serious and well-meaning scientists work for Big Pharma however the amount of money being tossed around is influencing the results, and what results are published. The design of a study can really affect the results you get. If you design a study to produce the results you want that’s a poor study.

  • An interesting focus might be on the antibiotics, antihypertensives, anti-cholesterol, etc., etc., drugs manufactured, sold and taken every day to keep people healthy and functioning beyond what normally they could have expected even 20 years ago

  • To be fair, it’s not “biotech” that’s the villain here, but unintended consequences, which are the villains of most dystopian fiction.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy